That’s the questions Peter Neumann and David Kim (2023) reply of their JAMA analysis letter revealed right now. They use 1990-2021 information from the Tufts Medical Middle CEA Registry. The outcomes are summarized within the graphs under.

First, we see the usage of a specific value effectiveness threshold growing over time, from solely 45% of revealed research to 91% of all research. Second, the cost-effectiveness thresholds have elevated over time. Whereas 43.6% of research reporting a CEA threshold used a $50,000/QALY threshold within the Nineteen Nineties, now solely 13.8% of research use that threshold; whereas 0% of research used $150,000/QALY threshold within the Nineteen Nineties, now 25.9% of research accomplish that.

The authors additionally observe that:

• Most cancers-related CEAs referenced greater thresholds than non-cancer CEAs, which can counsel a view that interventions for illnesses related to larger mortality and morbidity warrant greater thresholds.
• Authors of industry-funded analyses are inclined to reference greater thresholds.

You possibly can learn the complete paper right here.